ULS · Insider Trading
UL Solutions Inc.
Every open-market purchase and sale reported by ULS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-11-04 | Jennifer F. Scanlon | President and CEO | Sell | −12,500 | −$937.90K |
| 2026-10-09 | Jennifer F. Scanlon | President and CEO | Sell | −12,500 | −$876.04K |
| 2026-10-07 | Vikram Kini | Director | A | +278 deriv. | — |
| 2026-10-07 | Michael H Thaman | Director | A | +444 deriv. | — |
| 2026-09-14 | Friedrich Hecker | Director | A | +4 deriv. | — |
| 2026-09-14 | Michael H Thaman | Director | A | +4 deriv. | — |
| 2026-09-14 | Linda S Chapin | EVP & CHRO | A | +9 deriv. | — |
| 2026-09-14 | Ryan D Robinson | Executive VP & CFO | A | +39 deriv. | — |
| 2026-09-14 | James P Dollive | Director | A | +4 deriv. | — |
| 2026-09-14 | Charles W Hooper | Director | A | +19 deriv. | — |
| 2026-09-14 | Vikram Kini | Director | A | +4 deriv. | — |
| 2026-09-14 | Alex Dadakis | See Remarks | A | +40 deriv. | — |
| 2026-09-14 | Kevin Kennedy | Director | A | +19 deriv. | — |
| 2026-09-14 | Gitte Schjotz | See Remarks | A | +25 deriv. | — |
| 2026-09-14 | Marla C Gottschalk | Director | A | +19 deriv. | — |
| 2026-09-14 | James M Shannon | Director | A | +19 deriv. | — |
| 2026-09-14 | Jennifer F. Scanlon | President and CEO | A | +175 deriv. | — |
| 2026-09-14 | Sally Susman | Director | A | +19 deriv. | — |
| 2026-09-14 | George A Williams | Director | A | +19 deriv. | — |
| 2026-09-14 | Karen K Pepping | Senior VP & CAO | A | +3 deriv. | — |
| 2026-09-14 | Scott D'Angelo | EVP, CLO & Corporate Secy | A | +20 deriv. | — |
| 2026-09-14 | John A Genovesi | See Remarks | A | +14 deriv. | — |
| 2026-09-14 | Alberto Uggetti | EVP & CCO | A | +13 deriv. | — |
| 2026-09-14 | Elisabeth Torstad | Director | A | +19 deriv. | — |
| 2026-09-03 | Jennifer F. Scanlon | President and CEO | Sell | −12,500 | −$920.80K |
| 2026-08-10 | James M Shannon | Director | G | −600 | — |
| 2026-08-05 | Jennifer F. Scanlon | President and CEO | Sell | −12,500 | −$1.15M |
| 2026-07-08 | Michael H Thaman | Director | A | +340 deriv. | — |
| 2026-07-08 | Vikram Kini | Director | A | +213 deriv. | — |
| 2026-07-02 | Jennifer F. Scanlon | President and CEO | Sell | −12,500 | −$1.24M |
| 2026-06-10 | James P Dollive | Director | A | +3 deriv. | — |
| 2026-06-10 | Michael H Thaman | Director | A | +3 deriv. | — |
| 2026-06-10 | Sally Susman | Director | A | +14 deriv. | — |
| 2026-06-10 | John A Genovesi | See Remarks | A | +10 deriv. | — |
| 2026-06-10 | James M Shannon | Director | A | +14 deriv. | — |
| 2026-06-10 | Jennifer F. Scanlon | President and CEO | A | +128 deriv. | — |
| 2026-06-10 | Ryan D Robinson | Executive VP & CFO | A | +29 deriv. | — |
| 2026-06-10 | Karen K Pepping | Senior VP & CAO | Sell | −725 | −$70.86K |
| 2026-06-10 | Linda S Chapin | EVP & CHRO | A | +7 deriv. | — |
| 2026-06-10 | Gitte Schjotz | See Remarks | A | +18 deriv. | — |
| 2026-06-10 | Scott D'Angelo | EVP, CLO & Corporate Secy | A | +15 deriv. | — |
| 2026-06-10 | Charles W Hooper | Director | A | +14 deriv. | — |
| 2026-06-10 | Alex Dadakis | See Remarks | A | +28 deriv. | — |
| 2026-06-10 | Vikram Kini | Director | A | +3 deriv. | — |
| 2026-06-10 | George A Williams | Director | A | +14 deriv. | — |
| 2026-06-10 | Friedrich Hecker | Director | A | +3 deriv. | — |
| 2026-06-10 | Marla C Gottschalk | Director | A | +14 deriv. | — |
| 2026-06-10 | Lynn H Hancock | See Remarks | A | +8 deriv. | — |
| 2026-06-10 | Kevin Kennedy | Director | A | +14 deriv. | — |
| 2026-06-10 | Elisabeth Torstad | Director | A | +14 deriv. | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| ULSE Inc. | 10%+ Owner | 1,875,000 | $152.93M |
| Jennifer F. Scanlon | President and CEO | 206,209 | $16.82M |
| Ryan D Robinson | Executive VP & CFO | 166,514 | $13.58M |
| Frank J Coyne | Director | 112,069 | $9.14M |
| James P Dollive | Director | 79,160 | $6.46M |
| Marla C Gottschalk | Director | 71,428 | $5.83M |
| Gitte Schjotz | See Remarks | 59,341 | $4.84M |
| Weifang Zhou | See Remarks | 46,361 | $3.78M |
| Kevin Kennedy | Director | 35,714 | $2.91M |
| John A Genovesi | See Remarks | 31,013 | $2.53M |
| Linda S Chapin | EVP & CHRO | 22,918 | $1.87M |
| Lynn H Hancock | See Remarks | 21,904 | $1.79M |
| Friedrich Hecker | Director | 18,446 | $1.50M |
| Michael H Thaman | Director | 16,660 | $1.36M |
| George A Williams | Director | 8,928 | $728.17K |
| Karen K Pepping | Senior VP & CAO | 8,082 | $659.17K |
| Alberto Uggetti | EVP & CCO | 7,962 | $649.38K |
| James M Shannon | Director | 6,542 | $533.57K |
| Alex Dadakis | See Remarks | 5,806 | $473.54K |
| Lisa Marie Lambert | Director | 5,770 | $470.60K |
| Sally Susman | Director | 3,571 | $291.25K |
| Elisabeth Torstad | Director | 3,571 | $291.25K |
| Scott D'Angelo | EVP, CLO & Corporate Secy | 3,227 | $263.19K |
| Vikram Kini | Director | 2,805 | $228.78K |
| Charles W Hooper | Director | 357 | $29.12K |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the ULS quote page; the site-wide leaderboard is on the insider transactions hub.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.